ArticleEmerging infectious diseases2002
Invasive group a streptococcal infections, Israel.
Article in Emerging infectious diseases, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Burden of invasive group a streptococcus infection in Australia: a systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Review
- Acute kidney injury in pediatric toxic shock syndrome is associated with worse clinical course in the intensive care unit.European journal of pediatrics · 2023Observational
- Article
- Review
- Fulminant necrotizing streptococcal myositis with dramatic outcome - a rare case report.Medicine and pharmacy reports · 2021Article
- Valvular Heart Disease in a Young Israeli Ethiopian Immigrant Population From the Gondar Region With Implications for Rheumatic Heart Disease.Frontiers in public health · 2018Article
- Complete Genome Sequence ofGenome announcements · 2017Article
- Characterization of sil in invasive group A and G streptococci: antibodies against bacterial pheromone peptide SilCR result in severe infection.Infection and immunity · 2013Article
- Review
- Functional analysis of the quorum-sensing streptococcal invasion locus (sil).PLoS pathogens · 2009Article
- emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?Journal of clinical microbiology · 2007Article
- Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level.Journal of clinical microbiology · 2006Article
- Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis.Journal of clinical microbiology · 2005Article
- Toxic shock syndrome in children: epidemiology, pathogenesis, and management.Paediatric drugs · 2005Review
- Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001.Emerging infectious diseases · 2005Article
- Group G streptococcal bacteremia in Jerusalem.Emerging infectious diseases · 2004Article
- emm typing of M nontypeable invasive group A streptococcal isolates in Israel.Journal of clinical microbiology · 2003Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We conducted a prospective, nationwide, population-based study of invasive group A streptococcal infections in Israel. We identified 409 patients (median age 27 years; range <1-92), for an annual incidence of 3.7/100,000 (11/100,000 in Jerusalem). The mortality rate was 5%. Bacteremia occurred in 125 cases (31%). The most common illnesses were soft-tissue infection (63%) and primary bacteremia (14%). Thirty percent of patients had no identifiable risk factors for infection. Eighty-seven percent of pharyngeal carriers had the same serotype as the index patient. M types included M3 (25%), M28 (10%), and M-nontypable (33%). A marked paucity of M1 serotype (1.2%) was detected. The results highlighted concentrated pockets of invasive disease in the Jewish orthodox community (annual incidence 16/100,000).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.